TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15347773

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (600 mg twice daily for 3 months)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (10 adolescents without angiopathy and 8 healthy volunteers)
Number of subjects: 12
Study: 11669433

Group type: COMPARATOR
Intervention: Air-filled cuffs
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Distilled water-filled cuffs
Number of subjects: 60
Study: 9676083

Group type: EXPERIMENTAL
Intervention: Malstrom metal cup
Number of subjects: 90

Group type: COMPARATOR
Intervention: silicone rubber cup
Number of subjects: 90
Study: 7858934

Group type: EXPERIMENTAL
Intervention: Tropisetron (Navoban)
Number of subjects: 630
Study: 2789447

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 79

Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 79
Study: 631012

Group type: EXPERIMENTAL
Intervention: LAAM
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methadone
Number of subjects: 0
Study: 31111045

Group type: COMPARATOR
Intervention: Routine postoperative anti-inflammatory treatment (Cohort I)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Preoperative treatment (warming compress, lid hygiene, and anti-inflammatory treatment) and routine postoperative anti-inflammatory treatment (Cohort II)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Enhanced postoperative anti-inflammatory treatment (Cohort III)
Number of subjects: 120
Study: 27260944

Group type: EXPERIMENTAL
Intervention: Alcohol (AB)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fatal Vision Goggles (FVG)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo Beverage (PB)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo Goggles (PGs)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Subjective Mood Ratings (AB and FVG)
Number of subjects: 22
Study: 24919411

Group type: EXPERIMENTAL
Intervention: Motives for sports participation (achievement, health, social integration, fun and well-being)
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Baseline motives (achievement and fun and well-being)
Number of subjects: 121
Study: 23639300

Group type: EXPERIMENTAL
Intervention: Immediate Access to internet-based guided self-help program
Number of subjects: 66

Group type: COMPARATOR
Intervention: 6-week Delayed Access condition
Number of subjects: 66
Study: 16684261

Group type: EXPERIMENTAL
Intervention: H. pylori eradication therapy
Number of subjects: 542

Group type: COMPARATOR
Intervention: Standard of care (no eradication)
Number of subjects: 542
Study: 15156004

Group type: EXPERIMENTAL
Intervention: Clopidogrel pre-treatment (75 mg x 2 daily at least 48 hours before intervention)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Clopidogrel loading dose (300 mg at intervention time)
Number of subjects: 50
Study: 10937544

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Dyadic counseling
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Dual supportive seminar
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Early‐stage day care
Number of subjects: 103

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 103
Study: 8871769

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 1622057

Group type: EXPERIMENTAL
Intervention: Ender technique
Number of subjects: 120

Group type: COMPARATOR
Intervention: DHS technique
Number of subjects: 120
Study: 6721127

Group type: EXPERIMENTAL
Intervention: Halothane (NA)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Neurolept-analgesia (NLA)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Peridural anesthesia (PA)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 57
Study: 31596061

Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine with a loading dose of 1 μg/kg body weight followed by 0.2 μg/kg body weight/hour via continuous infusion
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intravenous ketamine 2 mg/kg body weight with atropine 0.01 mg/kg body weight
Number of subjects: 40
Study: 28129985

Group type: EXPERIMENTAL
Intervention: Pitolisant (5 mg, 10 mg, 20 mg, or 40 mg once daily)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo (once daily)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Pitolisant
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study: 25084070

Group type: EXPERIMENTAL
Intervention: Propranolol 240 mg/d
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 23884072

Group type: EXPERIMENTAL
Intervention: Immediate treatment with pegylated interferon (peg‐IFN) alfa‐2a plus self‐administered ribavirin (RBV)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Delayed treatment with pegylated interferon (peg‐IFN) alfa‐2a plus self‐administered ribavirin (RBV)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Delayed treatment (among those who received it)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Overall participants who received at least 1 dose of study medication
Number of subjects: 66
Study: 20506504

Group type: EXPERIMENTAL
Intervention: Colposcopically directed biopsies taken within 6 months of definitive therapy
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Same day biopsies
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Colposcopy with one degree of variance
Number of subjects: 737

Group type: EXPERIMENTAL
Intervention: Taking more than one biopsy
Number of subjects: 737
Study: 19434697

Group type: EXPERIMENTAL
Intervention: Stapler technique
Number of subjects: 70

Group type: COMPARATOR
Intervention: Stapler combined with seromuscular patch
Number of subjects: 70

Group type: COMPARATOR
Intervention: Both techniques
Number of subjects: 70
Study: 16479752

Group type: EXPERIMENTAL
Intervention: Immediately loaded tapered implants with single provisional crowns at surgery and definitive crowns 8 weeks later
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional 2-stage implants
Number of subjects: 0
Study: 12547850

Group type: EXPERIMENTAL
Intervention: Glimepiride
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (conventional treatment)
Number of subjects: 17
Study: 10861333

Group type: EXPERIMENTAL
Intervention: High fat diet (60 ± 6.7% fat)
Number of subjects: 14

Group type: COMPARATOR
Intervention: High carbohydrate diet (63 ± 3.2% carbohydrate)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Exercise (4190 kJ, 70% VO2max)
Number of subjects: 14
Study: 8618160

Group type: EXPERIMENTAL
Intervention: Total meniscectomy
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Partial meniscectomy
Number of subjects: 33

Group type: COMPARATOR
Intervention: Healthy contralateral knees
Number of subjects: 33
Study: 1526265

Group type: EXPERIMENTAL
Intervention: 1 microgram of alphacalcidol daily for 4 months
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 3903813

Group type: EXPERIMENTAL
Intervention: DL-phenylalanine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Open drug (DL-phenylalanine)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: L-phenylalanine
Number of subjects: 19
Study: 30576416

Group type: EXPERIMENTAL
Intervention: Alcohol beverage cues
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control (water) cues
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Executive functioning performance
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Alcoholic liver disease
Number of subjects: 17
Study: 29132842

Group type: EXPERIMENTAL
Intervention: 3.3% glucose/saline (51mEq/L sodium and 33g/L glucose)
Number of subjects: 130

Group type: COMPARATOR
Intervention: 5% glucose/saline (154mEq/L sodium and 50g/L glucose)
Number of subjects: 130
Study: 26242890

Group type: EXPERIMENTAL
Intervention: 8-week stress management and health promotion program
Number of subjects: 61

Group type: COMPARATOR
Intervention: Observational control program
Number of subjects: 61
Study: 24868587

Group type: EXPERIMENTAL
Intervention: Interdisciplinary treatment (experimental group)
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard pharmacological therapy (control group)
Number of subjects: 153
Study: 22466322

Group type: EXPERIMENTAL
Intervention: Q/LAIV
Number of subjects: 0

Group type: COMPARATOR
Intervention: T/LAIV
Number of subjects: 0
Study: 20723636

Group type: COMPARATOR
Intervention: QRS score 0 to 3 (<=10% myocardium)
Number of subjects: 4113

Group type: EXPERIMENTAL
Intervention: QRS score 4 to 7 (10% to 21% myocardium)
Number of subjects: 4113

Group type: EXPERIMENTAL
Intervention: QRS score >=8 (>21% myocardium)
Number of subjects: 4113
Study: 18540854

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 16200820

Group type: COMPARATOR
Intervention: Formoterol via Clickhaler
Number of subjects: 28

Group type: COMPARATOR
Intervention: Formoterol via Aerolizer
Number of subjects: 28

Group type: COMPARATOR
Intervention: Formoterol via pMDI
Number of subjects: 28
Study: 12358339

Group type: EXPERIMENTAL
Intervention: Montelukast added to ICS for 3 weeks (group M)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Inhaled corticosteroids (ICS) only (group C)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Montelukast withdrawal after 2 weeks (group M)
Number of subjects: 35
Study: 10364998

Group type: EXPERIMENTAL
Intervention: Diclofenac
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 30

Group type: COMPARATOR
Intervention: Saline (Placebo)
Number of subjects: 30
Study: 7863760

Group type: EXPERIMENTAL
Intervention: Intravenous cefuroxime (3 g infused in 15-25 min in preliminary study, 3 g infused in 15 min in main study)
Number of subjects: 40
Study: 1778193

Group type: EXPERIMENTAL
Intervention: Nisoldipine 5 mg twice a day
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Nisoldipine 10 mg daily
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 6785801

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 52
Study: 31529663

Group type: EXPERIMENTAL
Intervention: Intravenous administration of autologous bone marrow mononuclear cells (MNCs) at a target dose of 10 million cells per kilogram, administered within 24-72 hours of stroke onset.
Number of subjects: 25

Group type: COMPARATOR
Intervention: Intravenous administration of autologous bone marrow mononuclear cells (MNCs)
Number of subjects: 25
Study: 27554783

Group type: EXPERIMENTAL
Intervention: Cemented stems
Number of subjects: 23

Group type: COMPARATOR
Intervention: Hybrid stems
Number of subjects: 23
Study: 26373634

Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy (MBCT) in addition to treatment as usual (TAU)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) alone
Number of subjects: 120
Study: 23416800

Group type: EXPERIMENTAL
Intervention: Salbutamol with magnesium sulphate
Number of subjects: 120

Group type: COMPARATOR
Intervention: Salbutamol with normal saline
Number of subjects: 120
Study: 21242584

Group type: EXPERIMENTAL
Intervention: Imiquimod 5% cream (IMQ) once daily, 5 days/week for 6 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Radiotherapy (RT)
Number of subjects: 27
Study: 19568709

Group type: EXPERIMENTAL
Intervention: Rhodiola-Gingko Capsule (RGC), 270 mg herbal extracts, 4 capsules per day for 7 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 17353578

Group type: EXPERIMENTAL
Intervention: Regular red wine (250 ml)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Dealcoholized red wine (250 ml)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Cigarette smoking (one cigarette)
Number of subjects: 20
Study: 14753131

Group type: EXPERIMENTAL
Intervention: Intensified CHOP for patients ≤ 60 years; CHOP with growth factors for patients > 60 years (clinical trial group)
Number of subjects: 59

Group type: COMPARATOR
Intervention: CHOP chemotherapy in routine clinical practice (RCP)
Number of subjects: 59
Study: 11491635

Group type: EXPERIMENTAL
Intervention: Penicillin (28 capsules of 500 mg taken every 6 hours for 7 days)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 41
Study: 9306523

Group type: EXPERIMENTAL
Intervention: High-velocity procedure
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Low-amplitude procedure
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Initial posture variation
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: General findings
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Overall conclusion
Number of subjects: 11
Study: 8190329

Group type: EXPERIMENTAL
Intervention: Tidal peritoneal dialysis (TPD)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Continuous cyclic peritoneal dialysis (CCPD)
Number of subjects: 8
Study: 3286680

Group type: EXPERIMENTAL
Intervention: Percutaneous follicle aspiration
Number of subjects: 47

Group type: COMPARATOR
Intervention: Transvaginal puncture
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Percutaneous approach
Number of subjects: 47

Group type: COMPARATOR
Intervention: Transvaginal technique
Number of subjects: 47
Study: 29909091

Group type: EXPERIMENTAL
Intervention: LV5/FU2 + irinotecan
Number of subjects: 2982

Group type: COMPARATOR
Intervention: LV5/FU2
Number of subjects: 2982
Study: 26025780

Group type: EXPERIMENTAL
Intervention: Active rTMS (15 Hz)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 32
Study: 23833854

Group type: EXPERIMENTAL
Intervention: 0.5% hyperbaric bupivacaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 0.25% hyperbaric bupivacaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 5% hyperbaric lignocaine
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 2.5% hyperbaric lignocaine
Number of subjects: 80
Study: 20629481

Group type: EXPERIMENTAL
Intervention: Trial of Labor (TOL)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Vaginal Birth After Cesarean (VBAC)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Elective Repeat Cesarean Delivery (ERCD)
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Trial of Labor (TOL) with previa
Number of subjects: 203
Study: 18756940

Group type: EXPERIMENTAL
Intervention: Zoledronic acid 4 mg
Number of subjects: 228

Group type: COMPARATOR
Intervention: Pamidronate 90 mg
Number of subjects: 228
Study: 16809258

Group type: COMPARATOR
Intervention: Epidural anaesthesia (EDA) with ropivacaine + paracetamol (4 x 1 g tablet) + injected or oral morphine on demand
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oral oxycodone hydrochloride (2 x 10 mg tablet) + paracetamol (4 x 1 g tablet) + injected or oral morphine on demand
Number of subjects: 40
Study: 14516039

Group type: EXPERIMENTAL
Intervention: Autologous tricortical graft
Number of subjects: 42

Group type: COMPARATOR
Intervention: Cage
Number of subjects: 42
Study: 10566625

Group type: EXPERIMENTAL
Intervention: DHEA supplementation (50 mg/day for 3 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 10160231

Group type: EXPERIMENTAL
Intervention: Enhanced HRA feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typical HRA feedback
Number of subjects: 0

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 0
Study: 1870549

Group type: EXPERIMENTAL
Intervention: Lincomycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 0
Study: 6688799

Group type: EXPERIMENTAL
Intervention: Pirenzepine 50 mg per os daily for 6 months
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cimetidine 400 mg per os daily for 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Topical antacids as needed for 6 months
Number of subjects: 60
Study: 3926806

Group type: EXPERIMENTAL
Intervention: GHRH (1 microgram/kg, iv every 3 hours for 9-12 days)
Number of subjects: 7
Study: 29383606

Group type: EXPERIMENTAL
Intervention: Indigo carmine mixed solution
Number of subjects: 212

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 212
Study: 27378823

Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg bid 24 h prior to ascent
Number of subjects: 41

Group type: COMPARATOR
Intervention: High altitude exposure
Number of subjects: 41

Group type: COMPARATOR
Intervention: Baseline suPAR plasma concentration
Number of subjects: 41
Study: 24919538

Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 82
Study: 22778119

Group type: EXPERIMENTAL
Intervention: Interactive preventive health record (IPHR)
Number of subjects: 4500

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 4500

Group type: EXPERIMENTAL
Intervention: IPHR users
Number of subjects: 4500
Study: 20193645

Group type: EXPERIMENTAL
Intervention: Agomelatine 25 to 50 mg
Number of subjects: 313

Group type: COMPARATOR
Intervention: Sertraline 50 to 100 mg
Number of subjects: 313
Study: 18923706

Group type: EXPERIMENTAL
Intervention: Tribendimidine (200 mg for children, 400 mg for adults)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Albendazole (200 mg for children, 400 mg for adults)
Number of subjects: 123
Study: 16168630

Group type: EXPERIMENTAL
Intervention: Alprazolam 0.25 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Alprazolam 1.00 mg
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 12689685

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (reference group)
Number of subjects: 0
Study: 10685273

Group type: EXPERIMENTAL
Intervention: Maternal Care Manual of the Perinatal Education Programme
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 93
Study: 8712440

Group type: EXPERIMENTAL
Intervention: Enhanced education and individualized feedback on anesthesiologist performance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control hospital with usual practice
Number of subjects: 0
Study: 1754670

Group type: EXPERIMENTAL
Intervention: Food elimination diet (avoiding cows' milk, eggs, tomatoes, and possibly colours and preservatives)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Cows' milk and tomato food challenges
Number of subjects: 91

Group type: COMPARATOR
Intervention: Egg food challenge
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Duration of food avoidance
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Clinical history
Number of subjects: 91
Study: 6131526

Group type: EXPERIMENTAL
Intervention: Flurazepam (15 mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 31992133

Group type: EXPERIMENTAL
Intervention: Exercise-based warm-up programme ('VolleyVeilig')
Number of subjects: 672

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 672
Study: 31033140

Group type: EXPERIMENTAL
Intervention: Amnioexchange
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham procedure (Control)
Number of subjects: 64
Study: 29165021

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 327

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 327
Study: 26011606

Group type: EXPERIMENTAL
Intervention: High-threat condition (task described as very painful, high pain expressions depicted)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-threat condition (standard CPT instructions provided, low pain expressions depicted) with informed ceiling (maximum immersion time provided)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Low-threat condition (standard CPT instructions provided, low pain expressions depicted) with uninformed ceiling (information about maximum immersion time omitted)
Number of subjects: 48
Study: 23932198

Group type: EXPERIMENTAL
Intervention: Intra-articular tenoxicam injection (20 mg)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Arthrocentesis plus sodium hyaluronate injection
Number of subjects: 16
Study: 22341892

Group type: EXPERIMENTAL
Intervention: Continuous ropivacaine wound infusion
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine with saline wound infusion
Number of subjects: 66

Group type: COMPARATOR
Intervention: Saline wound infusion
Number of subjects: 66
Study: 20651413

Group type: EXPERIMENTAL
Intervention: Aquatic exercise and education (AE; aquatic exercise twice a week with once-a-week group education)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Aquatic exercise and education (AE)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Aquatics only (A; 2 week aquatic exercise)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control (C; usual activity)
Number of subjects: 79
Study: 18039987

Group type: EXPERIMENTAL
Intervention: Ongoing feedback regarding calculated coronary risk
Number of subjects: 3053

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 3053
Study: 16104026

Group type: EXPERIMENTAL
Intervention: Chiral bioanalytical method
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonchiral bioanalytical method
Number of subjects: 0
Study: 11231747

Group type: EXPERIMENTAL
Intervention: 200 IU/d of vitamin E
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 2000 IU/d of vitamin E
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 11284462

Group type: EXPERIMENTAL
Intervention: Rizatriptan 5 mg
Number of subjects: 1329

Group type: EXPERIMENTAL
Intervention: Rizatriptan 10 mg
Number of subjects: 1329

Group type: COMPARATOR
Intervention: Sumatriptan 25 mg
Number of subjects: 1329

Group type: COMPARATOR
Intervention: Sumatriptan 50 mg
Number of subjects: 1329

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1329
Study: 7821076

Group type: EXPERIMENTAL
Intervention: Gamma nail osteosynthesis
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: New gliding nail (GN)
Number of subjects: 330
Study: 3392410

Group type: COMPARATOR
Intervention: First period (1973-1981)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: Second period (1982-1987)
Number of subjects: 295
Study: 4923642

Group type: EXPERIMENTAL
Intervention: Isoprenaline
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31752094

Group type: EXPERIMENTAL
Intervention: Breastfeeding >24 months
Number of subjects: 307

Group type: EXPERIMENTAL
Intervention: Exclusive breastfeeding to six months with breastfeeding <24 months
Number of subjects: 307

Group type: COMPARATOR
Intervention: Never breastfed
Number of subjects: 307